Kelly M Chin

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi request reprint Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?
    Kelly M Chin
    Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, St Paul University Hospital, Dallas, TX, USA
    Chest 130:1657-63. 2006
  2. ncbi request reprint Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels
    Kelly M Chin
    Department of Internal Medicine, University of Texas Southwestern Pulmonary Hypertension Program, 5909 Harry Hines Blvd, Dallas, TX 75235 9254, USA
    Chest 132:786-92. 2007
  3. doi request reprint Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study
    Kelly M Chin
    UT Southwestern, Dallas, TX Electronic address
    Am Heart J 167:218-225.e1. 2014
  4. doi request reprint Characterizing the right ventricle: advancing our knowledge
    Kelly M Chin
    University of Texas Southwestern Medical Center, Dallas, Texas 75390 8550, USA
    Am J Cardiol 110:3S-8S. 2012
  5. doi request reprint Pulmonary arterial hypertension
    Kelly M Chin
    Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA
    J Am Coll Cardiol 51:1527-38. 2008
  6. doi request reprint Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension
    Kelly M Chin
    UT Southwestern Medical Center, Dallas, Texas, USA
    Am J Cardiol 101:1669-72. 2008
  7. doi request reprint Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension
    Kelly M Chin
    Department of Internal Medicine, University of Texas Southwestern Pulmonary Hypertension Program, Dallas, TX 75235 9254, USA
    Chest 135:130-6. 2009
  8. doi request reprint Association of cardiac troponin I with disease severity and outcomes in patients with pulmonary hypertension
    Mariella Velez-Martinez
    Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Am J Cardiol 111:1812-7. 2013
  9. pmc Left atrial structure and function and clinical outcomes in the general population
    Sachin Gupta
    Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, 75390 9047, USA
    Eur Heart J 34:278-85. 2013
  10. pmc Telomere shortening in familial and sporadic pulmonary fibrosis
    Jennifer T Cronkhite
    Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX 75390 8591, USA
    Am J Respir Crit Care Med 178:729-37. 2008

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?
    Kelly M Chin
    Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, St Paul University Hospital, Dallas, TX, USA
    Chest 130:1657-63. 2006
    ....
  2. ncbi request reprint Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels
    Kelly M Chin
    Department of Internal Medicine, University of Texas Southwestern Pulmonary Hypertension Program, 5909 Harry Hines Blvd, Dallas, TX 75235 9254, USA
    Chest 132:786-92. 2007
    ....
  3. doi request reprint Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study
    Kelly M Chin
    UT Southwestern, Dallas, TX Electronic address
    Am Heart J 167:218-225.e1. 2014
    ..Epoprostenol AM contains different inactive excipients, resulting in greater stability at room temperature compared with epoprostenol GM...
  4. doi request reprint Characterizing the right ventricle: advancing our knowledge
    Kelly M Chin
    University of Texas Southwestern Medical Center, Dallas, Texas 75390 8550, USA
    Am J Cardiol 110:3S-8S. 2012
    ....
  5. doi request reprint Pulmonary arterial hypertension
    Kelly M Chin
    Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA
    J Am Coll Cardiol 51:1527-38. 2008
    ..The purpose of this review is to describe the current state of evidence for the diagnosis, prognosis, and treatment of the patient with PAH...
  6. doi request reprint Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension
    Kelly M Chin
    UT Southwestern Medical Center, Dallas, Texas, USA
    Am J Cardiol 101:1669-72. 2008
    ..In conclusion, these results suggest that cardiac magnetic resonance imaging may have value in determining response to therapy and prognosis in patients with PAH...
  7. doi request reprint Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension
    Kelly M Chin
    Department of Internal Medicine, University of Texas Southwestern Pulmonary Hypertension Program, Dallas, TX 75235 9254, USA
    Chest 135:130-6. 2009
    ..In this study, we evaluate whether epoprostenol use, other PAH medication use, hemodynamics, or PAH etiology are associated with thrombocytopenia in PAH...
  8. doi request reprint Association of cardiac troponin I with disease severity and outcomes in patients with pulmonary hypertension
    Mariella Velez-Martinez
    Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Am J Cardiol 111:1812-7. 2013
    ..This hs assay has the potential to detect more at-risk patients and improve current risk-stratification algorithms...
  9. pmc Left atrial structure and function and clinical outcomes in the general population
    Sachin Gupta
    Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, 75390 9047, USA
    Eur Heart J 34:278-85. 2013
    ..Left atrial (LA) structural and functional abnormalities may be subclinical phenotypes, which identify individuals at increased risk of adverse outcomes...
  10. pmc Telomere shortening in familial and sporadic pulmonary fibrosis
    Jennifer T Cronkhite
    Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX 75390 8591, USA
    Am J Respir Crit Care Med 178:729-37. 2008
    ..Heterozygous mutations in the coding regions of the telomerase genes, TERT and TERC, have been found in familial and sporadic cases of idiopathic interstitial pneumonia. All affected patients with mutations have short telomeres...
  11. ncbi request reprint The right ventricle in pulmonary hypertension
    Kelly M Chin
    Division of Pulmonary and Critical Care Medicine, University of California, San Diego School of Medicine, La Jolla, California, USA
    Coron Artery Dis 16:13-8. 2005
    ..The article will review the normal structure and function of the right ventricle and summarize the impact of PAH and its treatments on right ventricular function...